AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,832,000 | -25.8% | 350,000 | 0.0% | 0.39% | -26.5% |
| Q2 2019 | $13,251,000 | -15.1% | 350,000 | -12.5% | 0.54% | -15.9% |
| Q1 2019 | $15,608,000 | +22.0% | 400,000 | -33.3% | 0.64% | +34.4% |
| Q4 2018 | $12,792,000 | +29.2% | 600,000 | +140.0% | 0.47% | +83.7% |
| Q3 2018 | $9,898,000 | +9.8% | 250,000 | +5.9% | 0.26% | +34.4% |
| Q2 2018 | $9,018,000 | +100.0% | 236,000 | +57.3% | 0.19% | +242.9% |
| Q1 2018 | $4,508,000 | -27.9% | 150,000 | -25.0% | 0.06% | -40.4% |
| Q4 2017 | $6,250,000 | +11.6% | 200,000 | 0.0% | 0.09% | -3.1% |
| Q3 2017 | $5,602,000 | – | 200,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |